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Abstract
Purpose The purpose of this study was to investigate the as-
sociation between body mass index (BMI) and the results of
SCARF osteotomy of the first metatarsal for hallux valgus
(HV) correction, as the literature on this is scant.
Methods This prospective study was carried out between 2011
and 2015. One hundred and thirty-three patients diagnosed
with moderate to severe HV underwent a SCARF corrective
osteotomy. We divided the patients into two groups according
to their BMI: normal and overweight. Postoperative follow-up
was two years. All patients were examined twice by two med-
ical doctors simultaneously: pre-operatively and post-
operatively at two years’ follow-up. Data collected included
biometrical records, X-rays [HV angle (HVA), intermetatarsal
angle (IMA), American Orthopaedic Foot and Ankle Society
Hallux Metatarsophalangeal Index (AOFAS-HMI) and visual
analogue scale (VAS) for pain and satisfaction].
Results There was a significant difference between patient age
(p = 0.001), age at onset (p < 0.001) and AOFAS-HMI
(p = 0.035) at follow-up. Other parameters were similar in
both groups.
Conclusion Regardless of BMI, the radiological outcome was
comparable. Despite a significant difference in AOFAS-HMI
results, pain and satisfaction level were similar. The authors
agreed that high BMI has protective role in the prevalence of
HV.
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Introduction
Hallux valgus (HV) is the most common forefoot deformation
in adults. It is characterised by medial deviation of the first
metatarsal with lateral deviation and rotation of the big toe,
which leads to bunion formation and difficulty walking in
footwear [1]. Its prevalence, depending on the source, is be-
tween 1:100 and 1:2 in adults. Despite its common occurrence
and numerous studies, there is lack of satisfactory data on HV.
One of the unexplored and significant issues is the influence
of body weight on the course, management and outcome of
HV treatment.
Excess weight is an increasing global problem involving
health and economic issues. It is known to be a risk factor for
kidney and cardiovascular diseases, cancers, diabetes and sud-
den death. Through excessive loads on the joints, it leads to
the development of osteoarthritis [2]. Each year, orthopaedic
surgeons treat a growing number of overweight patients facing
specific problems. This inclination impinges on the need to
study different aspects of body mass and its effect on possible
treatments. It is also known, that obesity worsens wound and
bone healing [3]. A number of studies acknowledged the neg-
ative influence of high body mass index (BMI) on total knee
replacement, such as poorer clinical outcome and higher revi-
sion rate than in normal-weight patients [4].
London et al. compared the rates of post-operative compli-
cations in obese and nonobese patients following elbow, fore-
arm and hand surgery [5]. According to their results,
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increasing BMI in the obese group was associated with greater
complication rates compared with the group with BMI within
the normal range. On the other hand, in a recent paper, Stewart
et al. concluded that number of complications after forefoot
surgery in obese patients was comparable with the nonobese
group [6]. The only difference noted was for infections; how-
ever, the authors presumed that this was due to higher inci-
dence of diabetes in the obese than the non-obese group rather
than being overweight itself. Regardless of weight, diabetic
patients were associated with significantly higher rates of
surgery-site infection (SSI). This finding corresponded with
other recent reports [7, 8].
Little is known about the role of obesity in the course,
management and outcome of HV. Limited results from avail-
able literature show extensive discrepancy among authors [9,
10]. This might be explained by selection bias because the
studies were not prospectively prepared. At the time of writing
this paper, no prospective study concerning the role of obesity
in the course, management and outcome of HV treatment had
been published. We conducted our study to address this issue.
Our aim was to investigate the association between being
overweight and clinical and radiological results of SCARF
osteotomy of the first metatarsal for HV correction (Table 1).
Materials and methods
This study was carried out at the University Hospital between
January 2011 and December 2015 and was approved by local
ethical committee (RNN/636/13/KB). During this period, 244
patients scheduled for HV surgery were reviewed. Inclusion
criteria were age >18 years, moderate to severe HV deforma-
tion based on the Manchester scale proposed by Garrow et al.
[9]. Patients who had undergone primary HV surgery and
presented recurrent deformation were excluded. Other prima-
ry exclusion criteria were underweight (BMI < 18.5), cigarette
smoking, diabetes mellitus, rheumatoid arthritis, lower limb
joint instability or axis deformity, recent trauma, neurological
conditions, peripheral vascular disease and severe first
metatarsophalangeal-joint arthrosis. These were based on the
Table 1 Patient dataset:
continuous variables presented as
medians with interquartile ranges
(IQR) and nominal variables
presented as numbers with
appropriate percentage
Parameter (n) G1 (n 71 (53%)) G2 (n 62 (47%)) P value
BMI (kg/m2) 23.05 (20.83–23.96) 27.37 (26.35–29.67)
Age (years) 52.0 (34.0–61.0) 61.0 (57.0–67.0) <0.001
Age at onset (years) 32.0 (16.0–43.0) 44.5 (37.0–54.0) <0.001
Symptoms-to-surgery period (years) 15.0 (10–25.0) 15.0 (8.0–20.0) 0.496
Side (left/right) 31:40 (43.7%) 32:30 (51.6%)
AOFAS-HMI
• Presurgery 47.0 (34.0–55.0) 46.0 (30.0–52.0) 0.252
• 2 years’ follow-up 80.0 (70.0-90.0) 75.0 (67.0–85.0) 0.035
• Difference (post–presurgery) 33.0 (26.0–40.0) 31.5 (22.0–41.0) 0.565
HVA
• Presurgery 39.0 (27.0–36.0) 33.0 (28.0–36.0) 0.325
• 2 years’ follow-up 14.0 (12.0–16.0) 14.0 (12.0–18.0) 0.247
• Difference (post–presurgery) 17.0 (15.0–21.0) 17.0 (14.0–22.0) 0.786
IMA
• Presurgery 13.0 (11.0–15.0) 13.0 (11.0–15.0) 0.652
• 2 years’ follow-up 8.0 (7.0–9.0) 9.0 (7.0–10.0) 0.113
• Difference (post–presurgery) 5.0 (3.0–6.0) 4.0 (3.0–6.0) 0.552
VAS for pain
• Presurgery 5.00 (4.00–6.00) 5.00 (4.00–6.00) 0.456
• 2 years’ follow-up 2.00 (1.00–3.00) 2.00 (1.00–2.00) 0.290
• Difference (post–presurgery) 3.00 (2.00–4.00) 3.00 (2.00–4.00) 0.371
Complications
• SSI 2 (2.82%) 2 (3.23%) 1.000
• Persistent pain 3 (4.23%) 4 (6.45%) 0.705
• Bone healing 2 (2.82%) 3 (4.84%) 0.664
• HVA postsurgery > 19° 8 (11.43%) 15 (24.19%) 0.089
BMI body mass index, HVA hallas vargas, AOFAS-HMI American Orthopaedic Foot and Ankle Society Hallux
Metatarsophalangeal Index, IMA intermetatarsal angle, VAS visual analogue scale, SSI surgery-site infection, G1
group 1, G2 group 2
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known correlation with complication rate and clinical out-
come [10]. One hundred and sixty-five patients met inclusion
criteria, gave written consent to participate and were included
in the study. There were only women.
Each patient was examined twice: pre-operatively, and two
years after surgery, by two authors (MM, KN). During the first
visit, medical data was collected: age, weight, height, comorbid-
ities, disease course, family history, running, wearing high heels,
tobacco use. All patients were examined clinically, and visual
analogue scale (VAS) for pain and American Orthopaedic Foot
and Ankle Society Hallux Metatarsophalangeal Index
(AOFAS-HMI) scores were collected [11]. AOFAS-HMI was
proven to be of high reliability and viability [12]. It comprises
three sections related to pain, function and alignment assess-
ment, with the worst score being 0 and the best 100. Worth
noting is the proven correlation of AOFAS-HMI score with
radiological results obtained after surgical correction of HV
was described [13]. VAS was used to evaluate pain, where 0 is
no pain and 10 is the worst pain possible. The load-bearing
anteroposterior (AP) X-ray was taken pre-operatively and both
HV angle (HVA) and intermetatarsal angle (IMA) were mea-
sured. Weight and height was obtained by a single qualified
nurse pre-operatively using RadwagWPT 100/200 OW person-
al medical scale. BMI was calculated as body mass divided by
the square of body height (kg/m2). Following that, patients were
classified as normal weight when BMI was 18.5–25 [group 1
(G1)] or overweight with BMI > 25) [group 2 (G2)].
SCARF corrective surgery was performed in all cases. A
single IV dose of antibiotic prophylaxis was administered pre-
operatively (second-generation cephalosporin). Anaesthesia
was induced via the subarachnoid space, after which a tourni-
quet was applied. The surgical technique was previously de-
scribed by Weil [14]. Briefly, following a medial approach, a
longitudinal Z-shape first metatarsal shaft osteotomy splits the
bone into two segments. The transverse cut was made hori-
zontally, distal dorsal and proximal plantar. Next, the plantar
segment was displaced laterally and the dorsal medially for
IMA to be reduced. Additional HVA decrease was obtained
by rotating the head of the first metatarsal. When satisfactory
adjustment was obtained, bone segments were fixed with two
2.5-mm cannulated cortical screws (Pyxis, EOS, France).
Afterwards, all patients underwent intermetatarsal-space
soft-tissue release, which included lateral capsulotomy,
intermetatarsal ligamentotomy and adductor halluces
tenotomy. Skin closure with continuous everting mattress su-
ture was performed and an elastic bandage applied. A Barouk
shoe to off-load pressure from the forefoot was used for six
weeks; no crutches were necessary, and immediate motion
was begun. Patients were given enoxaparin (40 mg SC daily)
prophylaxis for seven days post-operatively. Tramadol plus
paracetamol was prescribed for the pain control in the early
post-operative stage. No nonsteroidal anti-inflammatory drugs
were used. All patients were discharged home after one to two
days, and the stitches were removed after 14 days. Patients
who had a procedure other than SCARF osteotomy, such as
Akin proximal phalanx correction or hammer toe correction,
were excluded from the study (n = 59). Two patients were lost
to follow-up.; the final number of patients who reached the
two years’ follow-up was 133 (see Fig. 1).
Records were collected pre-operatively, and at the two year
follow-up examination, load-bearing X-ray, VAS for pain,
subjective foot appearance and AOFAS-HMI data were col-
lected. In addition, patients were again asked if they were
willing to give consent again, knowing the course and results
of the treatment beforehand. Load-bearing AP X-rays were
again taken during the final visit; HVA and IMA were both
remeasured. The angles were evaluated as previously de-
scribed by Coughlin et al. [15]. All radiograms were examined
by the same professional (MM). Clinical status was measured
again with AOFAS-HMI [11] and VAS for pain. VAS for
Fig. 1 Patient enrollment
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satisfaction with the treatment was collected: 0 for extremely
satisfied and 10 for extremely dissatisfied. Additionally, all
complications reported by patients during the two year
follow-up were recorded, validated and analysed.
Statistical analysis
Nominal variables are shown as numbers with appropriate
percentage whereas continuous variables are presented as me-
dians with interquartile ranges (IQR). Chi-square tests, with
appropriate corrections, were used to test associations be-
tween categorical variables. Statistica Software version 12.5
(StatSoft, Tulsa, OK, USA) was used for the analyses. P
values < 0.05 were considered as statistically significant.
Results
Among 133 patients with symptomatic HV 62 (47%) were
overweight (G2) and the remaining 71 (53%) had normal
BMI (G1). The average BMI in the whole cohort was 25.00
± 3.60 kg/m2, median values in G1 and G2 were 23.05 kg/m2
(IQR 20.83–23.94 kg/m2) and 27.37 kg/m2 (IQR 26.35–
29.67 kg/m2), respectively. BMI range is presented in Fig. 2.
Median age in G2 was nine years older than in G1: 61.0 years,
(IQR 57.0–67.0) vs. 52.0 years (IQR: 34.0–61.0), p < 0.001),
which corresponds with Polish population trends. The onset of
symptoms occurred earlier in G1 patients: 32.0 years (IQR:
16.0–43.0) vs. 44.5 years (IQR: 37.0–54.0); p < 0.001),
(Fig. 3). The period between first symptoms and orthopaedic
examination did not differ between groups (p = 0.496). There
were slight differences in terms of affected side: in G1, the
right side was affected more often (56%), while in G2, the left
foot lesions were more prevalent (52%).
We saw no significant differences in radiological parame-
ters between both groups. Median HVAs at both timepoints
are presented in Fig. 4. On pre-operative X-rays, median HVA
was 33.0 (IQR 27.0–36.0) while median IMAwas 13.0 (IQR
11.0–15.0). At follow-up, values were 14.0 (IQR 12.0–17.0)
and 8.50 (IQR 7.0–10.0), respectively. Pre-operative total
AOFAS-HMI (Fig. 5) was comparable between groups: 47.0
(IQR 34.0–55.0) in G1 vs. 46.0 (IQR 30.0–52.0) in G2;
p = 0.252. There was a significant difference in AOFAS-
HMI score at the follow-up, with non-obese patients achieving
better results: 80.0 (IQR 70.0–90.0) in G1 vs. 75.0 (IQR 67.0–
85.0); p = 0.035). When splitting it into partial results, we
found a significant correlation in activity score on primary
AOFAS-HMI (p < 0.001), and activity and shoes score in
function at the follow-up (p = 0.024 and p = 0.004, respective-
ly) in favour of G1.
Complications registered during the follow-up were as fol-
lows: SSI, persistent pain, inadequate correction and bone-
healing problems (delayed union, first metatarsal fracture
and metal migration). Post-operative SSI was noted in
2.82% (n = 2) patients from G1 and 3.23% (n = 2) in G2
(p = 1.000). All infections were successfully treated with an-
tibiotics, and no chronic inflammation or fistula formation was
reported. No patient required surgical debridement. Persistent
pain was noted in 4.23% (n = 3) and 6.45% (n = 4) patients,
respectively. Bone-healing problems were also similar (2.82%
and 4.84%, p = 0.664). There was one fracture in each group
that occurred due to noncompliance. We also reported one
metal migration in G2 and one delayed union in both groups.
The highest complication rate was represented by inadequate
Fig. 2 Body mass index (BMIC)
spread: horizontal bars represent
median, whiskers represent
interquartile range and dots
represent raw data
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correction (HVA > 19), which was observed in 15 patients
overall (11.28%). Although we noticed 9.85% (n = 7) in G1
and 12.90% (n = 8) in G2, no significant difference was found
(p = 0.089). Results of VAS for pain were similar between
groups at both timepoints. CMedian pain reduction level
was 3.0 units in both groups (p = 0.371).
Patients’ subjective foot appearance between groups in pre-
operative evaluation was identical (3.0, p = 1.000), and at two
years’ follow-up, no significant differences were found (1.4
vs. 1.5, p = 0.884). Median VAS for satisfaction score was 3.0
(IQR 2.00–4.00) in the normal weight group and 3.0 (IQR
2.00–3.00) in the overweight group (p = 0.339). Patients in
both groups gave their secondary consent for treatment
(92% vs. 89%, p = 0.797).
Discussion
To the authors’ knowledge, this article is the first report re-
garding the role of being overweight in the HV SCARF sur-
gery based on a prospective study. The mainstay of HV treat-
ment is reduction or complete abolition of pain and difficulty
wearing shoes, which are the most acute symptoms. The sec-
ondary goal is to improve foot functionality and aesthetics.
Fig. 3 Symptom onset:
horizontal bars represent median,
whiskers represent interquartile
range and dots represent raw data
Fig. 4 Hallus vargus (HVA)
results: horizontal bars represent
median, whiskers represent
interquartile range. Raw data
from the first timepoint (before
surgery) is presented as dots,
while raw data from the second
timepoint (2-years’ follow-up) is
presented as triangles
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This study aimed at comparing differences of prevalence and
outcome in consideration of BMI.
The overweight group was represented by patients
nine years older on average than those in the normal-weight
group. According to the Polish Central Statistical Office, this
observation meets national trends of increasing weight with
age.More interesting is the difference in age at symptom onset
between the groups. We noted a strong prevalence of HV
symptoms presenting at a younger age in patients within nor-
mal BMI range. Conversely, median onset in overweight pa-
tients was 12.5 years later. The influence of BMI on HV inci-
dence in the literature is inconsistent. In 1990, Wallace et al.
reported that high BMI has a protective role in the develop-
ment of HV [16]. A retrospective study by Frey and Zamora
investigated the association of the incidence of foot and ankle
complaints with BMI in 1411 patients [17]. They observed
that although being overweight brings a greater chance of
tendinitis, plantar fasciitis and osteoarthritis, normal-weight
patients are more likely to develop HV. Conversely, Cho
et al. reported that patients with higher BMI are more prone
to develop HV [13]. In 2010, the MOBILIZE Boston Study
reported that the prevalence of HV in women decreases with
increased BMI [18]. Our results were similar, with higher BMI
corresponding with older age at symptoms onset, and confirm
the protective role of being overweight on the development of
HV in women. Dufour and Golightly stated that great-toe
deformation was inversely associated with higher BMI in both
sexes [19, 20]. On the other hand, a recent study by Roddy
et al. presented no association between HV and BMI [17]. A
weak point of these studies was lack of radiological assess-
ment. An evaluation using a visual scale (or a diagram used in
this study) has legitimised application in clinical practice but
is likely to be less precise in research dependent on precise
data. We believe that higher body mass only postpones the
symptom onset and suggest further cohort studies with regard
to HV prevalence in BMI groups of different age and sex.
The results of VAS for satisfaction showed that most pa-
tients were satisfied with the surgical outcome and therapeutic
course, with similar median level of 3.0. Finally, patients
asked to give consent again for therapy responded positively
in ∼90% of cases. As there was no significant difference be-
tween groups, we believe that the described method of man-
aging HV is satisfactory for all patients regardless of BMI.
We observed similar radiological results between groups at
both timepoints. We suggest that the close to significant gain in
the number of HVA >19 at the follow-up (p = 0.089) in over-
weight patients can be explained by worse intra-operative ac-
cess and tougher, more difficult, rearrangement of cut bone
segments than in the normal-weight group due to excessive
fat tissue. Similar observations were mentioned in the literature
regarding different orthopaedic surgeries. Chen et al. reported a
sevenfold increase in repeat surgery due to obesity in their two
year postoperative studies [21]. It is questionable, however,
whether the phenomenon occurred regardless of the enrolment
of diabetic patients in their study or because of it. Future large-
scale studies are required to determine the reason.
It is debatable whether the distal metatarsal articulation
angle (DMAA) has any influence on complication rate. We
did not obtain DMAA data, as we met the ±3° diversity range
between different researchers. This observation is similar to
that in number of independent studies [22–24].
While our mean pre-operative AOFAS-HMI results were
comparable between groups, scores were slightly lower in the
obese group at follow-up. The explanation lies in partial re-
sults, where we observed a significant correlation between
activity and shoes score in the Function section in favour of
Fig. 5 American Orthopaedic
Foot and Ankle Society Hallux
Metatarsophalangeal Index
(AOFAS-HMI) results:
horizontal bars represent median,
whiskers represent interquartile
range. Raw data from the first
timepoint (before surgery) is
presented as dots, while raw data
from the second timepoint (2-
years’ follow-up) is presented as
triangles
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G1. We believe this is due to the psychological aspect of
patients with higher BMI, leading to avoidance of physical
activity and the pursuit of comfort, which is described widely
in the literature [25]. Excessive weight is a cause of musculo-
skeletal pain; previous studies prove the association of obesity
with low-back, knee and foot pain. In 2012, Butterworth et al.
presented a systematic review investigating the impact of ele-
vated BMI on foot disorders [26], particularly a significant
association between obesity and chronic foot pain—either
plantar or nonspecific. In our studies, VAS for pain associated
with HV deformity was similar between groups at both
timepoints (p = 0.456 and p = 0.290)., with median improve-
ment being 3.0. Nevertheless, AOFAS-HMI pain-related par-
tial results show a significant correlation between lower scores
in both groups at the follow-up. Interestingly, mean VAS pain
scores were 0.2 lower than in the normal-weight group. We
believe the reason lies in patient perception on both scales,
which in VAS focuses on pain level (toughness) and in
AOFAS on pain intensity in time.
There was similar incidence of SSI and other complica-
tions. The only issue close to significance was inadequate
correction in the overweight group, as discussed above.
Stewart et al. suggested that significant correlation of SSI
incidence and diabetes mellitus can be obtained with a
higher-power study [6]. Conversely, Chen et al. observed no
difference in complication rate when assessing the presence of
diabetes mellitus (DM) or BMI [21]. Wukich suggested that
the higher SSI rate in diabetic patients decreases if the disease
is well managed [7, 8]. Our study did not include diabetic
patients in order to avoid its hypothetical influence on out-
comes. We observed four cases of SSI and four ( two per
group, p = 1.000) of delayed bone healing, all of which were
successfully treated by the end of this study. Although seven
patients complained of persistent forefoot pain at the final
follow-up, no statistical correlation was found between
groups, with no significant effect on VAS pain score. As the
single cases of metal migration and first metatarsal fracture
were due to patient noncompliance, we were unable to study
possible relations. Interestingly, long-term clinical and radio-
logical results and complications observed in both groups
were similar to those presented by other authors studying
long-term issue [27–29]. Therefore, we see no influence of
BMI on SSI, delayed bone healing or persistent pain rates after
HV surgery.
Bock et al. [29] and Jeuken et al. [28] presented results of
SCARF osteotomy in their two year and 14-year follow-up
studies, respectively. They observed a gradual drop in clinical
and radiological outcome in both groups with time post-sur-
gery. As their two year follow-up results were similar to ours,
we expect similar decline. Interestingly, in the SCARF group,
78% recurrence was reported by Jeuken after 14 years.
Compared with our studies, this number is very high and we
do not expect to come close over a similar period. The reason
seems to be different characteristics of recurrence (HV angle
> 15° vs. HVA > 19°).
Weil and Bowen, in their epic paper on SCARF for HV
surgery, pointed out that disparity in long-term results may
occur due to a steep surgical learning curve [27]. They noted
that some authors observed as much as 35% complication rate
in their primary studies and as few as 1% in studies performed
a few years later. Whereas adding supplementary data from
different timepoints of the learning curve could result in a
huge divergence of findings, it seems appropriate to analyse
the same group of patients for mid- and long-term results.
In conclusion, this study confirms that SCARF osteotomy
can be recommended for treating moderate to severe HV re-
gardless of body weight. It results in a satisfactory correction
of angular deformities, good clinical outcome, reduced pain
and high patient satisfaction. There was no significant differ-
ence in complication rate between obese patients and those of
normal BMI.
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